SCHEMBL7249167

SCHEMBL7249167

C=C(c1ccc(F)cc1)c1ccc(N(CCC)CCC)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 2/20 0.43
ERBB2 P04626 2/20 0.43
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
THRB P10828 1/20 0.41
MAPK1 P28482 1/20 0.41
HTT P42858 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ESRRG P62508 1/20 0.40
POLB P06746 1/20 0.39
APEX1 P27695 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTR7 P34969 1/20 0.39
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
CNR2 P34972 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13675162 0.85 ALDH1A1 (0.47) EGFRERBB2KDM4EALDH1A1GAA
SCHEMBL612422 0.84 MEN1 (0.59) EGFRERBB2HTTMEN1KMT2A
SCHEMBL609858 0.78 EGFR (0.47) EGFRERBB2ALDH1A1GAAMAPT
SCHEMBL6338168 0.75 EGFR (0.51) EGFRERBB2KDM4EALDH1A1GAA
SCHEMBL1458445 0.75 ALDH1A1 (0.52) KDM4EALDH1A1GAAMAPTMAPK1
SCHEMBL10473319 0.75 EGFR (0.47) EGFRERBB2KDM4EALDH1A1GAA
SCHEMBL610171 0.75 MEN1 (0.56) EGFRERBB2KDM4EALDH1A1GAA
SCHEMBL7150414 0.74 EGFR (0.47) EGFRERBB2KDM4EALDH1A1GAA
SCHEMBL8865378 0.74 MAPT (0.55) MAPTHTTMEN1KMT2AMAOA
SCHEMBL11701589 0.74 KMT2A (0.44) EGFRERBB2ALDH1A1GAAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6555663-B1 Pharmaceuticals which are activated intracellularly by reaction with cellular electron carriers or free radicals to cause release of a free and active drug molecule MILLS RANDELL LEE (US) 2003-04-29 US disclosed
EP-0414730-B1 Chemical Compounds and pharmaceutical compositions capable of releasing a drug MILLS RANDELL L (US) 1999-12-15 EP disclosed
US-5773592-A COMPRISES A CHEMILUMINESCENT MOIETY, A PHOTOCHROMIC MOIETY AND A BIOLOGICALLY ACTIVE AGENT CAPABLE OF BEING RELEASED MILLS RANDELL LEE (US) 1998-06-30 US disclosed
US-5428163-A Luminides; chemiluminescence; redox system, releasing free drug MILLS RANDELL L (US) 1995-06-27 US disclosed
EP-0414730-A4 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS 1993-06-16 EP disclosed
EP-0414730-A1 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS Mills, Randell L. (US) 1991-03-06 EP disclosed
WO-1989009833-A1 LUMINIDE AND MACROLUMINIDE CLASS OF PHARMACEUTICALS MILLS RANDELL L (US) 1989-10-19 WO disclosed